06/09/2021Published by Fondazione Gianni Bonadonna at 06/09/2021Categories Events UncategorizedProstate cancer, a possible role for p38 inhibitors
30/08/2021Published by Fondazione Gianni Bonadonna at 30/08/2021Categories Events UncategorizedA bioinformatician comes back from Cambridge for the Gianni Bonadonna Foundation
23/08/2021Published by Fondazione Gianni Bonadonna at 23/08/2021Categories Events UncategorizedAnti-PD-1 therapy, evaluating tumor-specific MHC-II expression to predict clinical benefits
09/08/2021Published by Fondazione Gianni Bonadonna at 09/08/2021Categories Events UncategorizedAn effective immunotherapy for triple-negative breast cancer
26/07/2021Published by Fondazione Gianni Bonadonna at 26/07/2021Categories Events UncategorizedStop to applications for the first Gianni Bonadonna Foundation – AIRC Foundation Fellowship
19/07/2021Published by Fondazione Gianni Bonadonna at 19/07/2021Categories Events UncategorizedAgnospheres and molecular analysis to find therapies for tumors of unknown origin
12/07/2021Published by Fondazione Gianni Bonadonna at 12/07/2021Categories Events UncategorizedPoor results with venetoclax in advanced or metastatic breast cancer
05/07/2021Published by Fondazione Gianni Bonadonna at 05/07/2021Categories Events UncategorizedCancers of unknown origin, hope from MEK inhibitors
28/06/2021Published by Fondazione Gianni Bonadonna at 28/06/2021Categories EventsAdvanced urothelial cancer: questionable efficacy of durvalumab in combination with different targeted drugs
